| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83K | +150.8% | — |
| Cost of Revenue | $68K | +154.5% | — |
| Gross Profit | $15K | +135.7% | — |
| R&D Expense | $346K | -28.0% | -38.9% |
| SG&A Expense | $1.2M | +24.4% | -1.1% |
| Operating Income | -$1.6M | -6.8% | +13.8% |
| Net Income | -$1.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.0M | -19.5% | -53.0% |
| Accounts Receivable | $58K | — | — |
| Current Assets | $2.5M | -6.2% | -44.8% |
| Total Assets | $2.7M | -5.8% | -41.3% |
| Current Liabilities | $759K | +11.4% | -2.6% |
| Total Liabilities | $759K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | — |
| Financing Cash Flow | $997K | — | — |
| +12.0% |
| EPS (Basic) | -$0.15 | +0.0% | +31.8% |
| EPS (Diluted) | -$0.15 | +0.0% | +31.8% |
| +11.4% |
| -2.6% |
| Stockholders' Equity | $1.9M | -11.2% | -49.2% |